Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRB | P28702 | 6/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.38 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 6/20 | 0.37 |
| ▸ | RXRG | P48443 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.34 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.33 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29415451 | 1.00 | RXRB (0.39) | RXRBTDP1GABBR2GABBR1RXRA | |
| SCHEMBL1977392 | 0.92 | RXRB (0.34) | RXRBTDP1GABBR2GABBR1RXRA | |
| SCHEMBL4024339 | 0.83 | GABBR2 (0.36) | GABBR2GABBR1RXRAKDM4EALDH1A1 | |
| SCHEMBL8448354 | 0.78 | TPMT (0.36) | RXRBTDP1RXRARXRGAKR1C2 | |
| Hydrochloric Acid SCHEMBL7199340 | 0.77 | TPMT (0.35) | RXRBTDP1RXRARXRGAKR1C2 | |
| Hydrochloric Acid SCHEMBL5827032 | 0.77 | TPMT (0.35) | RXRBTDP1RXRARXRGAKR1C2 | |
| SCHEMBL547487 | 0.76 | ALDH1A1 (0.39) | TDP1GABBR2GABBR1KDM4EMEN1 | |
| SCHEMBL12587964 | 0.76 | GABBR2 (0.32) | GABBR2GABBR1KDM4EALDH1A1HPGD | |
| SCHEMBL811190 | 0.75 | POLB (0.39) | GABBR2GABBR1 | |
| SCHEMBL12587965 | 0.75 | GABBR2 (0.31) | GABBR2GABBR1RXRAKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116203119-B | MALDI-MS matrix for detecting small molecular compounds and detection method | 生物岛实验室 | 2024-02-06 | — | — | CN | claimed |
| CN-116203119-A | MALDI-MS matrix for detecting small molecular compounds and detection method | 生物岛实验室 | 2023-06-02 | — | — | CN | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| WO-2012051641-A1 | METAL OXIDE PARTICLES | UNIVERSITY OF QUEENSLAND (AU) | 2012-04-26 | — | — | WO | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| CN-116203119-B | MALDI-MS matrix for detecting small molecular compounds and detection method | 生物岛实验室 | 2024-02-06 | — | — | CN | disclosed |
| CN-116203119-A | MALDI-MS matrix for detecting small molecular compounds and detection method | 生物岛实验室 | 2023-06-02 | — | — | CN | disclosed |
| EP-0733216-A1 | A METHOD AND MATERIAL FOR THE DETECTION OF IONISING RADIATION | British Nuclear Fuels PLC (GB) | 1996-09-25 | — | — | EP | disclosed |
| WO-1995016210-A1 | A METHOD AND MATERIAL FOR THE DETECTION OF IONISING RADIATION | BRITISH NUCLEAR FUELS PLC (GB) | 1995-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | RXRB 407/4885TDP1 3338/4885GABBR2 2796/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | RXRB 1343/4885TDP1 1182/4885GABBR2 4009/4885 |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | RXRB 962/4885TDP1 3475/4885GABBR2 651/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | RXRB 727/4885TDP1 3912/4885GABBR2 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.